NOD2 Deficiency Impairs T Cell Recruitment to Gut Lymph Nodes in Infection Models

The study used adoptive transfer of SMARTA T cells into LCMV-infected mice with and without functional NOD2, followed by confocal microscopy and quantification at day 3 post-transfer. Parallel experiments employed a Listeria foodborne infection model. NOD2-deficient animals showed significantly fewer T cells reaching gut-draining lymph nodes and reduced capacity to control secondary challenges.

These results contradict the prevailing view that Crohn's arises primarily from hyperactive T cell responses. Instead, the data indicate that NOD2 variants first permit microbial persistence through defective antigen-specific T cell priming and recruitment. Increased intestinal permeability, already linked to NOD2 loss, then amplifies antigen exposure that the impaired adaptive response cannot clear.

The hypothesis aligns with clinical observations that anti-integrin and anti-TNF agents fail in a subset of patients, possibly those whose inflammation stems from unresolved low-level infections rather than primary immune excess. It also explains why NOD2 carriers show earlier onset and more fibrostenotic phenotypes in multiple cohorts.

Next steps require longitudinal human studies tracking T cell responses in NOD2 variant carriers before clinical diagnosis and testing whether early microbial clearance interventions alter disease trajectory.